Ravi Salgia, Md, Phd | What's Exciting About Lung Cancer At 2018 Best Of Asco St. Louis

Ravi Salgia, MD, PhD | What's Exciting About Lung Cancer at 2018 Best of ASCO St. Louis

Total Health | Oncology

ASCO Lung Cancer Update | Ravi Salgia, MD, PhD | 2022 Review and Renew Sedona

Total Health | Oncology

ASCO22 Lung Cancer Key Takeaways | Ravi Salgia, MD, PhD | 2022 Review and Renew Sedona

Total Health | Oncology

Dr. Ravi Salgia Describes Molecular Applications in Advanced Lung Cancer

Targeted Oncology

Dr. Salgia on Next-Generation Sequencing in Lung Cancer

2021 ASCO Direct San Francisco | Metastatic Lung Cancer Summary | Dr. Ravi Salgia

Total Health | Oncology

Meet Medical Oncologist and Chair Ravi Salgia, M.D., Ph.D. | City of Hope

Lecia Sequist, MD, MPH, Highlights Lung Cancer Research at ASCO 2024

MGHCancerCenter

Ravi Salgia, MD, PhD, outlines some of the molecular tests utilized prior to treating advanced NSCLC

Highlights in lung cancer from ASCO 2024

Ravi Salgia, MD, PhD, considers the unmet medical needs in the treatment of NSCLC

GRACEcastUC-059_Lung_Dr. Ravi Salgia on "My Approach to Maintenance Therapy for Advanced NSCLC"

GRACE - Global Resource for Advancing Cancer Education

Lung cancer at ASCO 2023: ADAURA and ADCs

2020 West Oncology Conference - Ravi Salgia, MD | Key Takeaways from the Immunotherapy Discussion

Total Health | Oncology

Ravi Salgia, MD, PhD, on treatment in the 2nd line setting after 1st line PD-L1 targeting agents

In Need of Cancer Screening or Surveillance? Don’t Let the Pandemic Stop You

GRACEcastUC108_Lung_Dr. Salgia on Targeted Therapies Generalizable

GRACE - Global Resource for Advancing Cancer Education

Best of ASCO 2024: What Patients Need to Know

Oncology Data Advisor

ASCO: Top Lung Cancer Studies

MDedge: news and insights for busy physicians

What Changes Monday Morning? | Post ASCO21 Lung Cancer Panel

Total Health | Oncology